Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function

Genomics

Volumn 83, Issue 6, 2004, Pages 970-979

  Xi, Tong ^a   Jones, Irene M ^a   Mohrenweiser, Harvey W ^a,b  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA repair genes; Genetic variation; Polymorphisms; Predicted protein activity

Indexed keywords

ENDONUCLEASE;

AMINO ACID SUBSTITUTION; ARTICLE; DNA REPAIR; GENE FREQUENCY; GENE SEQUENCE; GENETIC ALGORITHM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MASS SCREENING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN VARIANT;

ALGORITHMS; AMINO ACID SUBSTITUTION; COMPUTATIONAL BIOLOGY; DNA REPAIR; GENE FREQUENCY; GENETIC SCREENING; GENETICS, POPULATION; HUMANS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, PROTEIN; SOFTWARE;

EID: 2642527702     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygeno.2003.12.016     Document Type: Article

References (78)

1. Sachidanandam R., et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 409:2001;928-933
2. Cambien F., et al. Sequence diversity in 36 candidate genes for cardiovascular disorders. Am. J. Hum. Genet. 65:1999;183-191
3. Halushka M., et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat. Genet. 22:1999;239-247
4. Ohnishi Y., et al. Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population. Hum. Genet. 106:2000;288-292
5. Yamada R., et al. Identification of 142 single nucleotide polymorphisms in 41 candidate genes for rheumatoid arthritis in the Japanese population. Hum. Genet. 106:2000;293-297
6. Cargill M., et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22:1999;231-238
7. Iida A., et al. Catalog of 434 single-nucleotide polymorphisms (SNPs) in genes of the alcohol dehydrogenase, glutathione S-transferase, and nicotinamide adenine dinucleotide, reduced (NADH) ubiquinone oxidoreductase families. J. Hum. Genet. 46:2001;385-407
8. Small K.M., et al. Gene and protein domain-specific patterns of genetic variability within the G-protein coupled receptor superfamily. Am. J. Pharmacogenom. 3:2003;65-71
9. Leabman M.K., et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc. Natl. Acad. Sci. USA. 100:2003;5896-5901
10. Iida A., et al. Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8. J. Hum. Genet. 47:2002;285-310
11. Mohrenweiser H.W., Xi T., Vazquez-Matias J., Jones I.M. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol. Biomarkers Prev. 11:2002;1054-1064
12. Mohrenweiser H.W., Wilson D.M. 3rd, Jones I.M. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat. Res. 526:2003;93-125
13. Welcsh P.L., King M.C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10:2001;705-713
14. Muller A., Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest. 20:2002;102-109
15. Grossman L., et al. DNA repair as a susceptibility factor in chronic diseases in human populations. Dizdaroglu M., Karakaya A.E. Advances in DNA Damage and Repair. 1999;149-167 Kluwer Academic/Plenum, New York
16. Spitz M.R., Wei Q., Dong Q., Amos C.I., Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol. Biomarkers Prev. 12:2003;689-698
17. Wu X., et al. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung cancer cases and controls. Cancer. 83:1998;1118-1127
18. Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst. 92:2000;874-897
19. Berwick M., Matullo G., Vineis P. Studies of DNA repair and human cancer: an update. Wilson S.H., Suk W.A. Biomarkers of Environmentally Associated Disease: Technologies, Concepts and Perspectives. 2002;84-105 Lewis, Boca Raton, FL
20. Cloos J., et al. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J. Natl. Cancer Inst. 91:1999;1125-1130
21. Roberts S.A., et al. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer. Am. J. Hum. Genet. 65:1999;784-794
22. Hadi M.Z., Coleman M.A., Fidelis K., Mohrenweiser H.W., Wilson D.M. III Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res. 28:2000;3871-3879
23. Qiao Y., et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis. 23:2002;295-299
24. Qiao Y., et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat. Res. 509:2002;165-174
25. Wang Y., et al. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair. 2:2003;901-908
26. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 11:2002;1513-1530
27. Ng P.C., Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 11:2001;863-874
28. Ng P.C., Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12:2002;436-446
29. Ng P.C., Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 3:2003;3812-3814
30. Wang Z., Moult J. SNPs, protein structure, and disease. Hum. Mutat. 17:2001;263-270
31. Chasman D., Adams R.M. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J. Mol. Biol. 307:2001;683-706
32. Sunyaev S., et al. Prediction of deleterious human alleles. Hum. Mol. Genet. 10:2001;591-597
33. Sunyaev S., Ramensky V., Bork P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet. 16:2000;198-200
34. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30:2002;3894-3900
35. Sunyaev S.R., Lathe W.C. 3rd, Ramensky V.E., Bork P. SNP frequencies in human genes, an excess of rare alleles and differing modes of selection. Trends Genet. 16:2000;335-337
36. Fleming M.A., Potter J.D., Ramirez C.J., Ostrander G.K., Ostrander E.A. Understanding missense mutations in the BRCA1 gene: an evolutionary approach. Proc. Natl. Acad. Sci. USA. 100:2003;1151-1156
37. Wilson D.M. 3rd, Sofinowski T.M., McNeill D.R. Repair mechanisms for oxidative DNA damage. Front. Biosci. 8:2003;d963-d981
38. 2+ and specific amino acid residues in the catalytic reaction of the major human abasic endonuclease: new insights from EDTA-resistant incision of acyclic abasic site analogs and site-directed mutagenesis. J. Mol. Biol. 290:1999;447-457
39. Erzberger J.P., Barsky D., Scharer O.D., Colvin M.E., Wilson D.M. III Elements in abasic site recognition by the major human and Escherichia coli apurinic/apyrimidinic endonucleases. Nucleic Acids Res. 26:1998;2771-2778
40. Nguyen L.H., Barsky D., Erzberger J.P., Wilson D.M. III Mapping the protein-DNA interface and metal binding site of the major human apurinic/apyrimidinic endonuclease. J. Mol. Biol. 298:2000;447-459
41. Hadi M.Z., Ginalski K., Nguyen L.H., Wilson D.M. III Determinants in nuclease specificity of Ape1 and Ape2, human homologues of Escherichia coli exonuclease III. J. Mol. Biol. 316:2000;853-866
42. Wright A., Charlesworth B., Rudan I., Carothers A., Campbell H. A polygenic basis for late-onset disease. Trends Genet. 19:2003;97-106
43. Badano J.L., Katsanis N. Beyond Mendel: an evolving view of human genetic disease transmission. Nat. Rev. Genet. 3:2002;779-789
44. Zwick M.E., Cutler D.J., Chakravarti A. Patterns of genetic variation in Mendelian and complex traits. Annu. Rev. Genom. Hum. Genet. 1:2000;387-407
45. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517
46. Lander E.S. The new genomics: global views of biology. Science. 274:1996;536-539
47. Risch N.J. Searching for genetic determinants in the new millennium. Nature. 405:2000;847-856
48. Reich D.E., Lander E.S. On the allelic spectrum of human disease. Trends Genet. 17:2001;502-510
49. Cargill M., Daley G.Q. Mining for SNPs: putting the common variants-common disease hypothesis to the test. Pharmacogenomics. 1:2000;27-37
50. Barton N.H., Keightley P.D. Understanding quantitative genetic variation. Nat. Rev. Genet. 3:2002;11-21
51. Wong G.K., et al. A population threshold for functional polymorphisms. Genome Res. 13:2003;1873-1879
52. Wright J.D., Lim C. A fast method for predicting amino acid mutations that lead to unfolding. Protein Eng. 14:2001;479-486
53. Machicado C., Bueno M., Sancho J. Predicting the structure of protein cavities created by mutation. Protein Eng. 15:2002;669-675
54. Saunders C.T., Baker D. Evaluation of structural and evolutionary contributions to deleterious mutation prediction. J. Mol. Biol. 322:2002;891-901
55. Majewski J., Ott J. Amino acid substitutions in the human genome: evolutionary implications of single nucleotide polymorphisms. Gene. 305:2003;167-173
56. Ferrer-Costa C., Orozco M., de la Cruz X. Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. J. Mol. Biol. 31:2002;771-786
57. Stitziel N.O., et al. Structural location of disease-associated single-nucleotide polymorphisms. J. Mol. Biol. 327:2003;1021-1030
58. Santibanez Koref M.F., et al. A phylogenetic approach to assessing the significance of missense mutations in disease genes. Hum. Mutat. 22:2003;51-58
59. Miller M.P., Kumar S. Understanding human disease mutations through the use of interspecific genetic variation. Hum. Mol. Genet. 10:2001;2319-2328
60. Sokhansanj B.A., Rodrigue G.R., Fitch J.P., Wilson D.M. 3rd A quantitative model of human DNA base excision repair. I. Mechanistic insights. Nucleic Acids Res. 30:2002;1817-1825
61. Savas S., Knight J.A., Briollais L., Ozcelik H. Prediction of deleterious single nucleotide polymorphisms (SNPs) in DNA repair genes for breast cancer association studies. Cancer Epidemiol. Biomarkers Prev. 11:2002;1178
62. Henikoff S., Henikoff J.G. Performance evaluation of amino acid substitution matrices. Proteins. 17:1993;49-61
63. Grantham R. Amino acid difference formula to help explain protein evolution. Science. 185:1974;862-864
64. Chottiner E.G., Gribbin T.E., Ginsburg D., Mitchell B.S. Erythrocyte-specific overproduction of adenosine deaminase: molecular genetic studies. Prog. Clin. Biol. Res. 319:1989;55-64
65. Shu Y., et al. Evolutionary conservation predicts function of variants of the human organic cation transporter. OCT1, Proc. Natl. Acad. Sci. USA. 100:2003;5902-5907
66. Leabman M.K., et al. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics. 12:2002;395-405
67. Tirona R.G., Leake B.F., Merino G., Kim R.B. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J. Biol. Chem. 276:2001;35669-35675
68. Lee S.J., et al. Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups. Pharmacogenetics. 13:2003;461-472
69. Przybyla-Zawislak B.D., et al. Polymorphisms in human soluble epoxide hydrolase. Mol. Pharmacol. 64:2003;482-490
70. Blaisdell J., et al. Identification and functional characterization of new potentially defective alleles of human CYP2C19. Pharmacogenetics. 12:2002;703-711
71. King L.M., et al. Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol. Pharmacol. 61:2002;840-852
72. Dai D., et al. Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J. Pharmacol. Exp. Ther. 299:2001;825-831
73. Seker H., et al. Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res. 61:2001;7430-7434
74. Pastorelli R., Cerri A., Mezzetti M., Consonni E., Airoldi L. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int. J. Cancer. 100:2002;9-13
75. Bernstein C., Bernstein H., Payne C.M., Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 511:2002;145-178
76. Collins F.S., Brooks L.D., Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 8: 1998;1229-1231
77. Nickerson D.A., et al. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat. Genet. 19:1998;233-240
78. Shen M.R., Jones I.M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58:1998;604-608